Background: Better understanding of prognostic factors in tuboovarian high-grade serous carcinoma (HGSC) is critical, as diagnosis confers an aggressive disease course. Variation in tumor DNA methylation shows promise predicting outcome, yet prior studies were largely platform-specific and unable to evaluate multiple molecular features. Methods: We analyzed genome-wide DNA methylation in 1,040 frozen HGSC, including 325 previously reported upon, seeking a multi-platform quantitative methylation signature that we evaluated in relation to clinical features, tumor characteristics, time to recurrence/death, extent of CD8^þ tumor-infiltrating lymphocytes (TIL), gene expression molecular subtypes, and gene expression of the ATP-binding cassette transporter TAP1. Results: Methylation signature was associated with shorter time to recurrence, independent of clinical factors (N ¼ 715 new set, hazard ratio (HR), 1.65; 95% confidence interval (CI), 1.10–2.46; P ¼ 0.015; N ¼ 325 published set HR, 2.87; 95% CI, 2.17–3.81; P ¼ 2.2 * 10^-13) and remained prognostic after adjustment for gene expression molecular subtype and TAP1 expression (N ¼ 599; HR, 2.22; 95% CI, 1.66–2.95; P ¼ 4.1 * 10^-8). Methylation signature was inversely related to CD8^þ TIL levels (P ¼ 2.4 * 10^-7) and TAP1 expression (P ¼ 0.0011) and was associated with gene expression molecular subtype (P ¼ 5.9 * 10^-4) in covariate-adjusted analysis. Conclusions: Multi-center analysis identified a novel quantitative tumor methylation signature of HGSC applicable to numerous commercially available platforms indicative of shorter time to recurrence/death, adjusting for other factors. Along with immune cell composition analysis, these results suggest a role for DNA methylation in the immunosuppressive microenvironment. Impact: This work aids in identification of targetable epigenome processes and stratification of patients for whom tailored treatment may be most beneficial.

Dr

Dale Garsed

Honorary Conjoint Senior Fellow

The Sir Peter MacCallum Department of Oncology

Dr

Dale Garsed

Contact Dale

Division

Faculty of Medicine, Dentistry and Health Sciences

Dr

Dale Garsed

Print

Dale's Short Profile

Enquiries

Contact